Skip to main content
COGT
NASDAQ Life Sciences

Director-Affiliated Fund Files Intent to Sell $242.6M in Cogent Biosciences Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$38.5
Mkt Cap
$6.247B
52W Low
$3.72
52W High
$43.73
52W Position info
935% above low
Off High info
12% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

COGT has more than doubled off its 52-week low of $3.72 on elevated volume (2.2× avg).

Summary

A fund affiliated with a director of Cogent Biosciences has filed a Form 144 indicating intent to sell 7 million common shares valued at $242.6 million, following a conversion of preferred stock.


Key Events · Ownership and Investor Activity · COGT

  • Intent to Sell Significant Stake

    Fairmount Healthcare Fund II L.P., affiliated with a company director, filed a Form 144 to sell 7 million common shares.

  • Substantial Value

    The proposed sale is valued at approximately $242.6 million, representing a material portion of the company's market capitalization.

  • Conversion of Preferred Stock

    The shares intended for sale were acquired through the conversion of Series A Convertible Preferred Stock, indicating a strategic move to liquidate a position.

  • Follows Prior Sales

    This intent to sell follows the sale of 3.5 million shares by the same entity in the preceding three months, suggesting a pattern of distribution.


Analysis · COGT · Life Sciences

Fairmount Healthcare Fund II L.P., an investment vehicle managed by Fairmount Funds Management LLC, which has a director (Peter Harwin) on Cogent Biosciences' board, has filed a Form 144 to sell a substantial block of shares. This filing indicates an intent to sell 7 million common shares, valued at approximately $242.6 million, which were acquired through the conversion of Series A Convertible Preferred Stock. This proposed sale represents a significant distribution by a key insider-affiliated entity, following previous sales of 3.5 million shares in the last three months. The concurrent Schedule 13D/A filing confirms the execution of this sale, making this Form 144 a critical precursor to a major insider-affiliated divestment. This large-scale selling activity by a director-affiliated fund could signal a lack of conviction or a strategic portfolio rebalancing, potentially creating an overhang on the stock.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, COGT was trading at $38.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.2B. The 52-week trading range was $3.72 to $43.73. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

COGT - Latest Insights

COGT
Nov 05, 2026, 4:28 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $29.21
Real-time Price: $26.79 info
Change: -$2.42 (-8%) info
Market Cap: $4.669B info
COGT
Nov 05, 2026, 4:18 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $29.21
Real-time Price: $26.79 info
Change: -$2.42 (-8%) info
Market Cap: $4.669B info
COGT
Sep 15, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $33.50
Real-time Price: $26.79 info
Change: -$6.71 (-20%) info
Market Cap: $4.669B info
COGT
Aug 10, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $41.53
Real-time Price: $26.79 info
Change: -$14.74 (-35%) info
Market Cap: $4.669B info
COGT
Aug 10, 2026, 8:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $40.55
Real-time Price: $26.79 info
Change: -$13.76 (-34%) info
Market Cap: $4.669B info